Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Ther. 2013 Oct;7(5):196-200.

Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis.

Author information

ReGenera Research Group for Aging-Intervention, Milano, Italy.


The aim of this study was to test for a potential anticarcinogenic effect of Celergen, a marine derivative devoid of traceable amounts of inorganic arsenic, on cell proliferation, cell cycle progression and apoptosis in the HepG2 human liver cancer cell line. Celergen significantly inhibited the proliferation of cancer cells in a dose-dependent manner while limiting the cell cycle progression at the G1 phase and significantly inducing apoptosis. Further examination showed that Celergen enhanced expression of the p21(CIPl1WAF1), GADD153 genes and downregulated the c-myc gene. These results suggest that Celergen exerts promising chemopreventive properties to be further investigated.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for IRCA-BSSA Group
    Loading ...
    Support Center